Market Tracker

04/28 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

53.60
Delayed Data
As of Apr 28
 +0.83 / +1.57%
Today’s Change
31.38
Today|||52-Week Range
80.11
+43.16%
Year-to-Date

Today’s Trading

Previous close52.77
Today’s open52.80
Day’s range51.33 - 53.66
Volume489,397
Average volume (3 months)955,901
Market cap$4.6B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-7.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.35+0.30%
AGNPRAAllergan plc+3.01+0.35%
OPKOPKO Health Inc-0.06-0.77%
MNKMallinckrodt Plc+0.54+1.16%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts